TNNT2 and coronary artery disorder: MACEs occurred in 5 (9.3%, 5/54) patients in the NCA and normal hs-cTnT group, 2 (8.7%, 2/23) patients in the CAD and normal hs-cTnT group, 7 (13.2%, 7/53) patients in the NCA and elevated hs-cTnT group, and 9 (40.9%, 9/22) patients in the CAD and elevated hs-cTnT group.